Global Pharmacovigilance (PV) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • Market Overview

    The global Pharmacovigilance (PV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.2% in the forecast period of 2020 to 2025 and will expected to reach USD 8412.7 million by 2025, from USD 5708 million in 2019.


    The Pharmacovigilance (PV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.


    Market segmentation

    Pharmacovigilance (PV) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.


    By Type, Pharmacovigilance (PV) market has been segmented into:

    Spontaneous Reporting

    Intensified ADR Reporting

    Targeted Spontaneous Reporting

    Cohort Event Monitoring

    EHR Mining


    By Application, Pharmacovigilance (PV) has been segmented into:

    Hospitals

    Research Organizations

    Industrial


    Regions and Countries Level Analysis

    Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmacovigilance (PV) market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmacovigilance (PV) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmacovigilance (PV) market.


    The report offers in-depth assessment of the growth and other aspects of the Pharmacovigilance (PV) market in important countries (regions), including:

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

    South America (Brazil, Argentina, Colombia)

    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)


    Competitive Landscape and Pharmacovigilance (PV) Market Share Analysis

    Pharmacovigilance (PV) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pharmacovigilance (PV) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmacovigilance (PV) sales, revenue and market share for each player covered in this report.


    The major players covered in Pharmacovigilance (PV) are:

    Accenture

    Capgemini

    Laboratory Corporation of America Holdings

    Clinquest Group B.V.

    ICON plc.

    Cognizant

    iMEDGlobal

    ArisGlobal

    IBM Corporation

    ITClinical

    Wipro Ltd.

    Foresight Group International AG

    United BioSource Corporation

    BioClinica

    TAKE Solutions Ltd.

    PAREXEL International Corporation

     

  • Table of Contents

    1 Pharmacovigilance (PV) Market Overview

    1.1 Product Overview and Scope of Pharmacovigilance (PV)

    1.2 Classification of Pharmacovigilance (PV) by Type

    1.2.1 Global Pharmacovigilance (PV) Revenue by Type: 2015 VS 2019 VS 2025

    1.2.2 Global Pharmacovigilance (PV) Revenue Market Share by Type in 2019

    1.2.3 Spontaneous Reporting

    1.2.4 Intensified ADR Reporting

    1.2.5 Targeted Spontaneous Reporting

    1.2.6 Cohort Event Monitoring

    1.2.7 EHR Mining

    1.3 Global Pharmacovigilance (PV) Market by Application

    1.3.1 Overview: Global Pharmacovigilance (PV) Revenue by Application: 2015 VS 2019 VS 2025

    1.3.2 Hospitals

    1.3.3 Research Organizations

    1.3.4 Industrial

    1.4 Global Pharmacovigilance (PV) Market by Regions

    1.4.1 Global Pharmacovigilance (PV) Market Size by Regions: 2015 VS 2019 VS 2025

    1.4.2 Global Market Size of Pharmacovigilance (PV) (2015-2025)

    1.4.3 North America (USA, Canada and Mexico) Pharmacovigilance (PV) Status and Prospect (2015-2025)

    1.4.4 Europe (Germany, France, UK, Russia and Italy) Pharmacovigilance (PV) Status and Prospect (2015-2025)

    1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmacovigilance (PV) Status and Prospect (2015-2025)

    1.4.6 South America (Brazil, Argentina, Colombia) Pharmacovigilance (PV) Status and Prospect (2015-2025)

    1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmacovigilance (PV) Status and Prospect (2015-2025)

    2 Company Profiles

    2.1 Accenture

    2.1.1 Accenture Details

    2.1.2 Accenture Major Business and Total Revenue (Financial Highlights) Analysis

    2.1.3 Accenture SWOT Analysis

    2.1.4 Accenture Product and Services

    2.1.5 Accenture Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.2 Capgemini

    2.2.1 Capgemini Details

    2.2.2 Capgemini Major Business and Total Revenue (Financial Highlights) Analysis

    2.2.3 Capgemini SWOT Analysis

    2.2.4 Capgemini Product and Services

    2.2.5 Capgemini Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.3 Laboratory Corporation of America Holdings

    2.3.1 Laboratory Corporation of America Holdings Details

    2.3.2 Laboratory Corporation of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis

    2.3.3 Laboratory Corporation of America Holdings SWOT Analysis

    2.3.4 Laboratory Corporation of America Holdings Product and Services

    2.3.5 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.4 Clinquest Group B.V.

    2.4.1 Clinquest Group B.V. Details

    2.4.2 Clinquest Group B.V. Major Business and Total Revenue (Financial Highlights) Analysis

    2.4.3 Clinquest Group B.V. SWOT Analysis

    2.4.4 Clinquest Group B.V. Product and Services

    2.4.5 Clinquest Group B.V. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.5 ICON plc.

    2.5.1 ICON plc. Details

    2.5.2 ICON plc. Major Business and Total Revenue (Financial Highlights) Analysis

    2.5.3 ICON plc. SWOT Analysis

    2.5.4 ICON plc. Product and Services

    2.5.5 ICON plc. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.6 Cognizant

    2.6.1 Cognizant Details

    2.6.2 Cognizant Major Business and Total Revenue (Financial Highlights) Analysis

    2.6.3 Cognizant SWOT Analysis

    2.6.4 Cognizant Product and Services

    2.6.5 Cognizant Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.7 iMEDGlobal

    2.7.1 iMEDGlobal Details

    2.7.2 iMEDGlobal Major Business and Total Revenue (Financial Highlights) Analysis

    2.7.3 iMEDGlobal SWOT Analysis

    2.7.4 iMEDGlobal Product and Services

    2.7.5 iMEDGlobal Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.8 ArisGlobal

    2.8.1 ArisGlobal Details

    2.8.2 ArisGlobal Major Business and Total Revenue (Financial Highlights) Analysis

    2.8.3 ArisGlobal SWOT Analysis

    2.8.4 ArisGlobal Product and Services

    2.8.5 ArisGlobal Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.9 IBM Corporation

    2.9.1 IBM Corporation Details

    2.9.2 IBM Corporation Major Business and Total Revenue (Financial Highlights) Analysis

    2.9.3 IBM Corporation SWOT Analysis

    2.9.4 IBM Corporation Product and Services

    2.9.5 IBM Corporation Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.10 ITClinical

    2.10.1 ITClinical Details

    2.10.2 ITClinical Major Business and Total Revenue (Financial Highlights) Analysis

    2.10.3 ITClinical SWOT Analysis

    2.10.4 ITClinical Product and Services

    2.10.5 ITClinical Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.11 Wipro Ltd.

    2.11.1 Wipro Ltd. Details

    2.11.2 Wipro Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

    2.11.3 Wipro Ltd. SWOT Analysis

    2.11.4 Wipro Ltd. Product and Services

    2.11.5 Wipro Ltd. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.12 Foresight Group International AG

    2.12.1 Foresight Group International AG Details

    2.12.2 Foresight Group International AG Major Business and Total Revenue (Financial Highlights) Analysis

    2.12.3 Foresight Group International AG SWOT Analysis

    2.12.4 Foresight Group International AG Product and Services

    2.12.5 Foresight Group International AG Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.13 United BioSource Corporation

    2.13.1 United BioSource Corporation Details

    2.13.2 United BioSource Corporation Major Business and Total Revenue (Financial Highlights) Analysis

    2.13.3 United BioSource Corporation SWOT Analysis

    2.13.4 United BioSource Corporation Product and Services

    2.13.5 United BioSource Corporation Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.14 BioClinica

    2.14.1 BioClinica Details

    2.14.2 BioClinica Major Business and Total Revenue (Financial Highlights) Analysis

    2.14.3 BioClinica SWOT Analysis

    2.14.4 BioClinica Product and Services

    2.14.5 BioClinica Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.15 TAKE Solutions Ltd.

    2.15.1 TAKE Solutions Ltd. Details

    2.15.2 TAKE Solutions Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

    2.15.3 TAKE Solutions Ltd. SWOT Analysis

    2.15.4 TAKE Solutions Ltd. Product and Services

    2.15.5 TAKE Solutions Ltd. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    2.16 PAREXEL International Corporation

    2.16.1 PAREXEL International Corporation Details

    2.16.2 PAREXEL International Corporation Major Business and Total Revenue (Financial Highlights) Analysis

    2.16.3 PAREXEL International Corporation SWOT Analysis

    2.16.4 PAREXEL International Corporation Product and Services

    2.16.5 PAREXEL International Corporation Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    3.1 Global Pharmacovigilance (PV) Revenue and Share by Players (2015-2020)

    3.2 Market Concentration Rate

    3.2.1 Top 5 Pharmacovigilance (PV) Players Market Share

    3.2.2 Top 10 Pharmacovigilance (PV) Players Market Share

    3.3 Market Competition Trend

    4 Market Size by Regions

    4.1 Global Pharmacovigilance (PV) Revenue and Market Share by Regions

    4.2 North America Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    4.3 Europe Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    4.4 Asia-Pacific Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    4.5 South America Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    4.6 Middle East & Africa Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    5 North America Pharmacovigilance (PV) Revenue by Countries

    5.1 North America Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    5.2 USA Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    5.3 Canada Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    5.4 Mexico Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    6 Europe Pharmacovigilance (PV) Revenue by Countries

    6.1 Europe Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    6.2 Germany Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    6.3 UK Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    6.4 France Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    6.5 Russia Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    6.6 Italy Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Pharmacovigilance (PV) Revenue by Countries

    7.1 Asia-Pacific Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    7.2 China Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    7.3 Japan Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    7.4 Korea Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    7.5 India Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    7.6 Southeast Asia Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    8 South America Pharmacovigilance (PV) Revenue by Countries

    8.1 South America Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    8.2 Brazil Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    8.3 Argentina Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Pharmacovigilance (PV) by Countries

    9.1 Middle East & Africa Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    9.2 Saudi Arabia Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    9.3 UAE Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    9.4 Egypt Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    9.5 South Africa Pharmacovigilance (PV) Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    10.1 Global Pharmacovigilance (PV) Revenue and Market Share by Type (2015-2020)

    10.2 Global Pharmacovigilance (PV) Market Forecast by Type (2019-2024)

    10.3 Spontaneous Reporting Revenue Growth Rate (2015-2025)

    10.4 Intensified ADR Reporting Revenue Growth Rate (2015-2025)

    10.5 Targeted Spontaneous Reporting Revenue Growth Rate (2015-2025)

    10.6 Cohort Event Monitoring Revenue Growth Rate (2015-2025)

    10.7 EHR Mining Revenue Growth Rate (2015-2025)

    11 Global Pharmacovigilance (PV) Market Segment by Application

    11.1 Global Pharmacovigilance (PV) Revenue Market Share by Application (2015-2020)

    11.2 Pharmacovigilance (PV) Market Forecast by Application (2019-2024)

    11.3 Hospitals Revenue Growth (2015-2020)

    11.4 Research Organizations Revenue Growth (2015-2020)

    11.5 Industrial Revenue Growth (2015-2020)

    12 Global Pharmacovigilance (PV) Market Size Forecast (2021-2025)

    12.1 Global Pharmacovigilance (PV) Market Size Forecast (2021-2025)

    12.2 Global Pharmacovigilance (PV) Market Forecast by Regions (2021-2025)

    12.3 North America Pharmacovigilance (PV) Revenue Market Forecast (2021-2025)

    12.4 Europe Pharmacovigilance (PV) Revenue Market Forecast (2021-2025)

    12.5 Asia-Pacific Pharmacovigilance (PV) Revenue Market Forecast (2021-2025)

    12.6 South America Pharmacovigilance (PV) Revenue Market Forecast (2021-2025)

    12.7 Middle East & Africa Pharmacovigilance (PV) Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

    14 Appendix

    14.1 Methodology

    14.2 Data Source

    14.3 Disclaimer

    14.4 About US

     

This is a single user license, allowing one specific user access to the product.

This is a 1-10 user licence, allowing up to ten users have access to the product.

This is a site license, allowing all users within a given geographical location of your organisation access to the product.

Need Assistance ?

Our Clients